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Abstract: 
In the present research work gastro retentive mucoadhesive floating formulation of Metformin was developed by 
using various hydrophilic polymers. Initially analytical method development was done for the drug molecule. 
Absorption maxima was determined based on that calibration curve was developed by using different concentrations. 
Gas generating agent accrual and bioadhesive polymer carbopol concentration was optimized. Then the formulation 
was developed by using different concentrations of polymers of various polymers. The formulation blend was 
subjected to various preformualation studies, flow properties and all the formulations were found to be good 
indicating that the powder blend has good flow properties. Among all the formulations the formulations prepared 
with HPMC K15M retarded the drug release up to 12 hours in the concentration of  220mg (F10).The formulations 
prepared with HPMC K4M and HPMC K100M released drug less than 12 hours. Hence they were not considered. 
The optimized formulation dissolution data was subjected to release kinetics, from the release kinetics data it was 
evident that the formulation followed zero order kinetics of drug release. 
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INTRODUCTION: 
The oral route is increasingly being used for the 
delivery of therapeutic agents because the low cost of 
the therapy and ease of administration lead to high 
levels of patient compliance. More than 50%of the 
drug delivery systems available in the market are oral 
drug delivery systems [1-5]. 
Significance of Floating Bioadhesive Dosage Form 
(FBDF) [6-10]:  
Individual disadvantages of Floating dosage form & 
bioadhesive can be avoided if used a combination of 
both approaches as a Floating with bioadhesion at the 
time available the full gastric media in stomach will 
be dosage form float over the surface when stomach 
is empty at the time dosage form is adhere to the 
stomach mucosa prevent the passage of the stomach 
and dosage form is retained in stomach prolong 
period of time get the drug release in sustained 
manner. 
Merits of FBDF:  
1) It avoids disadvantages of the single 
gastroretentive drug delivery system by using the 
Combinational approach of floating with 
bioadhesive. 
2) Decrease the frequency of drug administration. 
3) Increase the desired residence of drug at the site of 
action mainly in the stomach. 
3) Minimize the side effects. 
4) Minimize the cost of treatment. 
5) Improvement of patient compliance.  
 
Demerits of FBDF:  
Following of category of drug are unsuitable for 
FBDF  
1) Drugs that cause gastric lesions like NSAID & 
Aspirin. 
2) Drugs that have very limited acid solubility like 
Phenytoin. 
3) Bioadhesion in the acidic environment and high 
turnover of mucus may raise doubts about the 
usefulness of Floating with bioadhesion 
FDDS approach may be used for various potential 
active agents with narrow absorption window, e.g. 
antiviral, antifungal and antibiotic agents 
(sulphonamides, quinolones, penicillins, 
cephalosporins, aminoglycosides and tetracyclines) 
which are absorbed from very specific regions of GI 
tract and whose development has been halted due to 
the lack of appropriate pharmaceutical technologies. 
In addition, by continual supplying the drug to its 
most efficient site of absorption, the dosage form 
may allow for more effective oral use of peptide and 
protein drugs such as calcitonin, erythropoetin, 
vasopressin, insulin, low molecular weight heparin, 
and LHRH. Some of the unresolved critical issues 
related to the rational development of FDDS include, 
the quantitative efficiency of floating delivery 
systems in the fasted and fed states and the 
correlation between prolonged GRT and SR/PK 
characteristics. However, we areas close as we have 
ever been to see a greater transition of gastric 
retention devices from developmental level to the 
manufacturing and commercial level. 
 
Materials Used: 
Metformin-Natco LABS, HPMC K4M-Merck 
Specialities Pvt Ltd, Mumbai, India, HPMC K15M-
SD fine chemical, Mumbai, India, HPMC K100M-
SD fine chemical, Mumbai, India, Carbopol 934P-
 SD fine chemical, Mumbai, India, Carbopol 
971P-SD fine chemical, Mumbai, India, Accural-
Merck Specialities Pvt Ltd, Mumbai, India, 
Magnesium stearate-Merck Specialities Pvt Ltd, 
Mumbai, India, Micro crystalline cellulose- Heligent 
pharma, Mumbai, India, Talc-SD fine chemical, 
Mumbai, India. 
METHODS: 
Analytical method development: 
a)Determination of absorption maxima: 
A solution containing the concentration 10 µg/ ml 
drug was prepared in 0.1N HCl UV spectrum was 
taken using Double beam UV/VIS spectrophotometer. 
The solution was scanned in the range of 200 – 400. 
Drug – Excipient compatibility studies 
Fourier Transform Infrared (FTIR) spectroscopy: 
The physical properties of the physical mixture were 
compared with those of plain drug. Samples was 
mixed thoroughly with 100mg potassium bromide IR 
powder and compacted under vacuum at a pressure of 
about 12 psi for 3 minutes. The resultant disc was 
mounted in a suitable holder in Perkin Elmer IR 
spectrophotometer and the IR spectrum was recorded 
from 3500 cm to 500 cm. The resultant spectrum was 
compared for any spectrum changes. 
Preformulation parameters 
The quality of tablet, once formulated by rule, is 
generally dictated by the quality of physicochemical 
properties of blends. There are many formulations and 
process variables involved in mixing and all these can 
affect the characteristics of blends produced. The 
various characteristics of blends tested as per 
Pharmacopoeia. 
Formulation development of Tablets: 
All the formulations were prepared by direct 
compression. The compression of different 
formulations is given in Table 6.3.The tablets were 
prepared as per the procedure given below and aim is 
IAJPS 2017, 4 (09), 3202-3209        G.Jagadeesh and Vijaya Kuchana           ISSN 2349-7750 
 
 w w w . i a j p s . c o m  
 
Page 3204 
to prolong the release of Metformin. Total weight of 
the tablet was considered as 1150mg. 
Procedure:  
1.Metformin and all other ingredients were 
individually passed through sieve   no  60. 
2.All the ingredients were mixed thoroughly by 
triturating up to 15 min. 
3.The powder mixture was lubricated with talc. 
4.The tablets were prepared by using direct 
compression method. 
Optimization of Accural concentration: 
Accural was employed as effervescent gas generating 
agent. It helps the formulation to float. Various 
concentrations of accural were employed; floating lag 
time and floating duration were observed. Based on 
that the concentration of accural was finalized and 
preceded for further formulations. 
 
Table 1: Optimization accural concentration 
S.No Excipient Name EF1 EF2 EF3 
1 Metformin 500 500 500 
2 HPMCK 4M 180 180 180 
4 CARBOPOL 934P 100 100 100 
5 Accrual 60 120 180 
5 Mg.Stearate 12 12 12 
7 Talc 12 12 12 
8 MCC pH 102  Q.S Q.S Q.S 
Total weight 1150 1150 1150 
                     All the quantities were in mg. 
Based on the floating lag time and floating duration the concentration of accural was optimised. 
 
Table 2: Formulation composition for floating tablets 
Formulation 
No. 
Metformin 
 
HPMC 
K4M 
 
HPMC 
K15M 
 
HPMC 
K100M 
 
Accural 
 
Carbopol 
934P 
Carbopol 
971P 
Mag. 
Stearate 
Talc 
 
 
MCC 
pH 
102 
F1 500 80 ----- ----- 120 100 100 12 12 QS 
F2 500 120 ----- ----- 120 100 100 12 12 QS 
F3 500 180 ----- ----- 120 100 100 12 12 QS 
F4 500 ----- 80 ----- 120 100 100 12 12 QS 
F5 500 ----- 120 ----- 120 100 100 12 12 QS 
F6 500 ----- 180 ----- 120 100 100 12 12 QS 
F7 500 ----- ----- 80 120 100 100 12 12 QS 
F8 500 ----- ----- 120 120 100 100 12 12 QS 
F9 500 ----- ----- 180 120 100 100 12 12 QS 
F10 500 220 ----- ----- 120 100 100 12 12 QS 
F11 500 ----- 220 ----- 120 100 100 12 12 QS 
F12 500 ----- ----- 220 120 100 100 12 12 QS 
All the quantities were in mg, Total weight is 1150 mg. 
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Evaluation of   post compression parameters for 
prepared Tablets 
The designed compression tablets were studied for 
their physicochemical properties like weight variation, 
hardness, thickness, friability and drug content.  
RESULTS AND DISCUSSION: 
Preformulation parameters of powder blend 
Tablet powder blend was subjected to various pre-
formulation parameters. The angle of repose values 
indicates that the powder blend has good flow 
properties. The bulk density of all the formulations 
was found to be in the range of   0.43±0.07 to 
0.58±0.06 (gm/cm3) showing that the powder has 
good flow properties. The tapped density of all the 
formulations was found to be in the range of   0.57 to 
0.69 showing the powder has good flow properties. 
The compressibility index of all the formulations was 
found to be ranging between   16 to 18 which show 
that the powder has good flow properties. All the 
formulations has shown the hausner ratio ranging 
between  0 to 1.2 indicating the powder has good 
flow properties. 
Optimization of Accural concentration: 
Three formulations were prepared with varying 
concentrations of sodium bicarbonate. The 
formulation containing sodium bicarbonate in 50mg 
concentration showed less floating lag time of 4 min 
and the tablet was in floating condition for more than 
12 hours. 
Quality Control Parameters For tablets: 
Tablet quality control tests such as weight variation, 
hardness, and friability, thickness, and drug release 
studies in different media were performed on the 
tablets.  
Table 3: quality control parameters for tablets 
 
 
 
 
Formulation 
code 
Weight 
variation(mg) 
Hardness(kg/cm2) 
Friability 
(%loss) 
Thickness 
(mm) 
Drug 
content 
(%) 
 
Floating 
lag time 
(min)  
F1 1155 3.5 0.52 
4.8 
99.76 
4.0 
F2 1143 3.2 0.54 
4.9 
99.45 
4.2 
F3 1149 3.4 0.51 
4.9 
99.34 
4.5 
F4 1152 3.5 0.55 
4.9 
99.87 
4.1 
F5 1150 3.4 0.56 
4.7 
99.14 
4.0 
F6 1148 3.2 0.45 
4.5 
98.56 
4.4 
F7 1147 3.1 0.51 
4.4 
98.42 
4.5 
F8 1151 3.3 0.49 
4.7 
99.65 
4.6 
F9 1153 3.5 0.55 
4.6 
99.12 
4.7 
F10  1145 3.5 0.45 
4.5 
98.42 
4.5 
F11 1146 3.4 0.51 
4.4 
99.65 
4.6 
F12 1149 3.2 0.49 
4.7 
99.12 
4.7 
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Table 4: Detachment forces of different formulations.(bioadhesive strength) 
S. number Formulation code (F) Detachment force (dynes/cm2) 
   1   F1     133.45 
2  F2     141.74 
3  F3     137.53 
4  F4     146.72 
5  F5     130.42 
6  F6     149.65 
7  F7     147.80 
8  F8     132.18 
9  F9     130.21 
10  F10     146.24 
11  F11     153.78 
12  F12     155.26 
All the parameters such as weight variation, friability, hardness, thickness and drug content were found to be within 
limits. 
In-Vitro Drug Release Studies 
 
 
 
Fig 1:dissolution profiles of formulations 
F1-F3 
 
Fig 2: dissolution profiles of formulations 
F5-F6 
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Fig 3:dissolution profiles of formulations 
F7-F9 
 
Fig 4: dissolution profiles of formulations 
F10-F12 
Table 5: Determination of swelling index 
S. number Formulation code (F) swelling index(%) 
                          1             F1             95.23 
2   F2    101.42 
3   F3    110.36 
4   F4    104.87 
5   F5    110.25 
6   F6    115.78 
7   F7    99.45 
8   F8    105.55 
9   F9    109.63 
10   F10    124.5 
11   F11    119.35 
12   F12    118.53 
 
From the data observed from  graphs it was evident that the formulation F3 was followed Zero order kinetics. 
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Fourier Transform-Infrared Spectroscopy: 
1349.022  20.209
1297.876  11.655
1147.032  6.5511036.828  12.661
938.397  7.250
828.880  28.553
688.972  24.777
582.018  17.021
525.282  24.282
454.843  14.607
443.773  -0.000
419.623  53.304
403.606  26.650
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Fig 5: FT-TR Spectrum of Metformin pure drug. 
 
Fig 6: FT-IR Spectrum of Optimized Formulation 
CONCLUSION:  
 In the present research work gastro retentive 
mucoadhesive floating formulation of 
Metformin by using various hydrophilic 
polymers.  
 Initially analytical method development was 
done for the drug molecule. Absorption 
maxima was determined based on that 
calibration curve was developed by using 
different concentrations. Gas generating 
agent accrual and bioadhesive polymer 
carbopol concentration was optimized.  
 Then the formulation was developed by 
using different concentrations of polymers of 
various polymers.  
 The formulation blend was subjected to 
various preformualation studies, flow 
properties and all the formulations were  
 
found to be good indicating that the powder 
blend has good flow properties.  
 Among all the formulations the formulations 
prepared with HPMC K15M retarded the 
drug release up to 12 hours in the 
concentration of  220mg (F10). 
 The formulations prepared with HPMC K4M 
and HPMC K100M released drug less than 
12 hours. Hence they were not considered.  
 The optimized formulation dissolution data 
was subjected to release kinetics, from the 
release kinetics data it was evident that the 
formulation followed zero order kinetics of 
drug release. 
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